Senti Historical Cash Flow
| SNTI Stock | USD 4.67 0.48 11.46% |
Analysis of Senti Biosciences cash flow over time is an excellent tool to project Senti Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 3.5 M or Capital Expenditures of 13.7 M as it is a great indicator of Senti Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Senti Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Senti Biosciences is a good buy for the upcoming year.
Senti |
About Senti Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Senti balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Senti's non-liquid assets can be easily converted into cash.
Senti Biosciences Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Capital Expenditures
Capital Expenditures are funds used by Senti Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Senti Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Senti Biosciences financial statement analysis. It represents the amount of money remaining after all of Senti Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Senti Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Senti Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Senti Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.As of now, Senti Biosciences' Other Cashflows From Investing Activities is decreasing as compared to previous years.
| 2023 | 2024 | 2025 (projected) | Sale Purchase Of Stock | 512K | 588.8K | 389.4K | Dividends Paid | 404K | 464.6K | 441.4K |
Senti Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Senti Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Senti Biosciences cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | 12.5M | (5.5M) | (40.6M) | (19.1M) | (17.2M) | (16.4M) | |
| Change In Cash | 25.2M | 28.3M | 1.7M | (21.5M) | (19.4M) | (18.4M) | |
| Stock Based Compensation | 272K | 2.3M | 16.4M | 9.7M | 11.1M | 6.3M | |
| Free Cash Flow | (25.3M) | (40.2M) | (76.3M) | (64.4M) | (58.0M) | (60.9M) | |
| Change In Working Capital | (1.8M) | 615K | 13.9M | 4.7M | 5.4M | 3.9M | |
| Other Cashflows From Financing Activities | 30.1M | 68.4M | 112.6M | 375K | 431.3K | 409.7K | |
| Depreciation | 2.0M | 3.0M | 3.9M | 5.4M | 6.2M | 3.5M | |
| Other Non Cash Items | (5.0M) | 14.7M | (10.9M) | (1.1M) | (990.9K) | (941.4K) | |
| Capital Expenditures | 1.2M | 5.5M | 41.4M | 12.0M | 13.8M | 13.7M | |
| Total Cash From Operating Activities | (24.2M) | (34.6M) | (34.9M) | (52.4M) | (47.2M) | (49.5M) | |
| Change To Account Receivables | (10K) | (395K) | (131K) | 507K | 583.1K | 612.2K | |
| Net Income | (19.9M) | (55.3M) | (58.2M) | (71.1M) | (64.0M) | (67.1M) | |
| Total Cash From Financing Activities | 38.1M | 68.4M | 118.6M | 779K | 895.9K | 851.1K | |
| End Period Cash Flow | 31.0M | 59.3M | 61.0M | 39.4M | 45.4M | 43.2M |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Senti Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.59) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.